Cargando…
Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption
Duchenne muscular dystrophy (DMD) is not currently part of mandatory newborn screening, despite the availability of a test since 1975. In the absence of screening, a DMD diagnosis is often not established in patients until 3–6 years of age. During this time, irreversible muscle degeneration takes pl...
Autores principales: | Parad, Richard B., Sheldon, Yvonne, Bhattacharjee, Arindam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629008/ https://www.ncbi.nlm.nih.gov/pubmed/34842620 http://dx.doi.org/10.3390/ijns7040077 |
Ejemplares similares
-
Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022) -
A Roadmap to Newborn Screening for Duchenne Muscular Dystrophy
por: Al-Zaidy, Samiah A., et al.
Publicado: (2017) -
A pilot study of newborn screening for Duchenne muscular dystrophy in Guangzhou
por: Jia, Xuefang, et al.
Publicado: (2022) -
Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan
por: Chien, Yin-Hsiu, et al.
Publicado: (2022) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)